Sensitivity: The minimum detectable dose of Rat PCSK9 was determined to be approximately 47 pg/ml. This is defined as at least three times standard deviations above the mean optical density of 10 replicates of the zero standard. Detection: 47 pg/ml
Sensitivity: The minimum detectable dose of Human SULT1E1 was determined to be approximately 31.25 pg/ml. This is defined as at least three times standard deviations above the mean optical density of 10 replicates of the zero standard. Detection: 31.25 pg/ml
Sensitivity: The minimum detectable dose of Human CIB2 was determined to be approximately 15.6 pg/ml. This is defined as at least three times standard deviations above the mean optical density of 10 replicates of the zero standard. Detection: 15.6 pg/ml
Sensitivity: The minimum detectable dose of Human Vasorin / VASN was determined to be approximately 23.4 pg/ml. This is defined as at least three times standard deviations above the mean optical density of 10 replicates of the zero standard. Detection: 23.4 pg/ml
Sensitivity: The minimum detectable dose of human VEGFR3 / FLT4 was determined to be approximately 156.1 pg/ml. This is defined as at least three times standard deviations above the mean optical density of 10 replicates of the zero standard. Detection: 156.1 pg/ml
Sensitivity: The minimum detectable dose of Human DPP7 / DPPII / DPP2 was determined to be approximately 62.5 pg/ml. This is defined as at least three times standard deviations above the mean optical density of 10 replicates of the zero standard. Detection: 62.5 pg/ml
Sensitivity: The minimum detectable dose of Human Junctional Adhesion Molecule A / JAM-A was determined to be approximately 7.8 pg/ml. This is defined as at least three times standard deviations above the mean optical density of 10 replicates of the zero standard. Detection: 7.8 pg/ml
Sensitivity: The minimum detectable dose of human C1s was determined to be approximately 78.1 pg/ml. This is defined as at least three times standard deviations above the mean optical density of 10 replicates of the zero standard. Detection: 78.1 pg/ml
Sensitivity: The minimum detectable dose of Human CD83 was determined to be approximately 3.9 pg/ml. This is defined as at least three times standard deviations above the mean optical density of 10 replicates of the zero standard. Detection: 3.9 pg/ml
Sensitivity: The minimum detectable dose of Human Tetranectin / CLEC3B was determined to be approximately 55 pg/ml. This is defined as at least three times standard deviations above the mean optical density of 10 replicates of the zero standard. Detection: 55 pg/ml
Sensitivity: The minimum detectable dose of human CD8A was determined to be approximately 78.1 pg/ml. This is defined as at least three times standard deviations above the mean optical density of 10 replicates of the zero standard. Detection: 78.1 pg/ml
Sensitivity: The minimum detectable dose of Human TIM-3 / HAVCR2 / TIMD3 was determined to be approximately 31.25 pg/ml. This is defined as at least three times standard deviations above the mean optical density of 10 replicates of the zero standard. Detection: 31.25 pg/ml
Sensitivity: The minimum detectable dose of Human CD19 was determined to be approximately 234.38 pg/ml. This is defined as at least three times standard deviations above the mean optical density of 10 replicates of the zero standard. Detection: 234.38 pg/ml
Sensitivity: The minimum detectable dose of Human TNF-alpha / TNFA / TNFSF2 was determined to be approximately 23.44 pg/ml. This is defined as at least three times standard deviations above the mean optical density of 10 replicates of the zero standard. Detection: 23.44 pg/ml
Sensitivity: The minimum detectable dose of Human PNLIP was determined to be approximately 15.63 pg/ml. This is defined as at least three times standard deviations above the mean optical density of 10 replicates of the zero standard. Detection: 15.63 pg/ml